Most countries in sub-Saharan Africa not on track for under-5 mortality reduction goal

March 13, 2019

The relatively slow pace of neonatal and under-5 mortality reduction could prevent most countries in sub-Saharan Africa from achieving targets set in Sustainable Development Goal 3 (SDG-3) by 2030, according to a study published March 12 in the open-access journal PLOS Medicine by Iván Mejía-Guevara of Stanford University, USA and colleagues.

Despite the sharp decline in global under-5 deaths since 1990, uneven progress has been achieved across and within countries. SDG-3 aims to reduce neonatal mortality rates to fewer than 12 per 1,000 live births and under-5 mortality rates to at least as low as 25 per 1,000 births by 2030. But concerns exist as to whether countries in the region will meet these key goals for under-5 mortality, and analysis that explores sources of variation is needed to address these concerns. To address this need, Mejía-Guevara and colleagues used data from full birth histories to develop a new demographic model to assess age patterns of mortality, fit mortality profiles across age and time, and forecast under-5 mortality. The data came from 106 nationally representative demographic and health surveys with full birth histories from 31 sub-Saharan African countries from 1990 to 2017.

The mortality model revealed declines of death rates at every age in most countries, but with notable differences. The average annual reduction for under-5 mortality rates between 1990 and 2017 was 3.2%, but it varied from 0.1% in Lesotho to 5.2% in Malawi. The authors predict that 5 countries (Kenya, Rwanda, Senegal, Tanzania, and Uganda) are on track to achieve the under-5 mortality SDG target by 2030, but only Rwanda and Tanzania would meet both the neonatal and under-5 mortality targets simultaneously. According to the authors, the findings should be considered in the design and scale-up of targeted interventions intended to accelerate progress toward achieving the SDG-3 targets for child mortality reduction.
-end-
Research Article

Funding:

The authors received no specific funding for this work.

Competing Interests:

The authors have declared that no competing interests exist.

Citation:

Mejía-Guevara I, Zuo W, Bendavid E, Li N, Tuljapurkar S (2019) Age distribution, trends, and forecasts of under-5 mortality in 31 sub-Saharan African countries: A modeling study. PLoS Med 16(3): e1002757. https://doi.org/10.1371/journal.pmed.1002757

Author Affiliations:

Department of Biology, Stanford University, Stanford, California, United States of America Center for Population Health Sciences, Stanford University School of Medicine, Stanford, California, United States of America Primary Care and Population Health, Stanford University School of Medicine, Stanford, California, United States of America United Nations Population Division, New York, New York, United States of America

In your coverage please use this URL to provide access to the freely available paper: http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002757

PLOS

Related Mortality Articles from Brightsurf:

Being in treatment with statins reduces COVID-19 mortality by 22% to 25%
A research by the Universitat Rovira i Virgili (URV) and Pere Virgili Institut (IISPV) led by Lluís Masana has found that people who are being treated with statins have a 22% to 25% lower risk of dying from COVID-19.

Mortality rate higher for US rural residents
A recent study by Syracuse University sociology professor Shannon Monnat shows that mortality rates are higher for U.S. working-age residents who live in rural areas instead of metro areas, and the gap is getting wider.

COVID-19, excess all-cause mortality in US, 18 comparison countries
COVID-19 deaths and excess all-cause mortality in the U.S. are compared with 18 countries with diverse COVID-19 responses in this study.

New analysis shows hydroxychloroquine does not lower mortality in COVID-19 patients, and is associated with increased mortality when combined with the antibiotic azithromycin
A new meta-analysis of published studies into the drug hydroxychloroquine shows that it does not lower mortality in COVID-19 patients, and using it combined with the antibiotic azithromycin is associated with a 27% increased mortality.

Hydroxychloroquine reduces in-hospital COVID-19 mortality
An Italian observational study contributes to the ongoing debate regarding the use of hydroxychloroquine in the current pandemic.

What's the best way to estimate and track COVID-19 mortality?
When used correctly, the symptomatic case fatality ratio (sCFR) and the infection fatality ratio (IFR) are better measures by which to monitor COVID-19 epidemics than the commonly reported case fatality ratio (CFR), according to a new study published this week in PLOS Medicine by Anthony Hauser of the University of Bern, Switzerland, and colleagues.

COVID-19: Bacteriophage could decrease mortality
Bacteriophage can reduce bacterial growth in the lungs, limiting fluid build-up.

COPD and smoking associated with higher COVID-19 mortality
Current smokers and people with chronic obstructive pulmonary disease (COPD) have an increased risk of severe complications and higher mortality with COVID-19 infection, according to a new study published May 11, 2020 in the open-access journal PLOS ONE by Jaber Alqahtani of University College London, UK, and colleagues.

Highest mortality risks for poor and unemployed
Large dataset shows that income, work status and education have a clear influence on mortality in Germany.

Addressing causes of mortality in Zambia
Despite the fact that people in sub-Saharan Africa are now living longer than they did two decades ago, their average life expectancy remains below that of the rest of the world population.

Read More: Mortality News and Mortality Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.